Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for Tenders 2009 > News item |
PDL BioPharma buys $55 million 2% convertibles, 2.75% convertibles
By Devika Patel
Knoxville, Tenn., July 30 - PDL BioPharma, Inc. said it bought back $55 million of its 2% convertible notes due in 2012 and its 2.75% convertible senior notes due 2023 in open market purchases.
PDL is a Wilmington, N.C., pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.